Date published: 2026-3-31

1-800-457-3801

SCBT Portrait Logo
Seach Input

mAChR M3 Inhibitors

Muscarinic Acetylcholine Receptors (mAChRs) are a class of G protein-coupled receptors (GPCRs) that play a crucial role in mediating the effects of the neurotransmitter acetylcholine (ACh) in the central nervous system (CNS) and peripheral tissues. These receptors are named after muscarine, a natural alkaloid compound found in certain mushrooms, which can selectively activate them. There are five subtypes of mAChRs, designated as M1 through M5, each encoded by a distinct gene. These receptor subtypes exhibit distinct anatomical distribution patterns and signaling mechanisms, allowing for diverse physiological responses to acetylcholine. mAChRs are integral membrane proteins composed of seven transmembrane helices (TMHs) connected by intracellular and extracellular loops. They are primarily found on the plasma membrane of postsynaptic neurons, smooth muscles, and other cell types throughout the body. Additionally, some mAChRs are also present in presynaptic terminals, where they regulate neurotransmitter release. Upon binding acetylcholine, mAChRs undergo conformational changes that activate their intracellular signaling pathways. Activation of mAChRs leads to the dissociation of the heterotrimeric G proteins into Gα and Gβγ subunits. The Gα subunit then modulates the activity of various effector proteins, such as ion channels and enzymes, resulting in diverse physiological responses.The different mAChR subtypes display varying affinities for acetylcholine and selective agonists or antagonists. For instance, M1, M3, and M5 subtypes primarily couple to Gq/11 proteins, which activate phospholipase Cβ (PLCβ) and subsequently elevate intracellular calcium levels and activate protein kinase C (PKC). On the other hand, M2 and M4 subtypes predominantly couple to Gi/o proteins, which inhibit adenylate cyclase (AC) and reduce cyclic AMP (cAMP) levels, leading to downstream effects mediated by cAMP-dependent protein kinase (PKA). Due to their extensive distribution and involvement in various physiological processes, mAChRs have profound effects on the nervous, cardiovascular, respiratory, gastrointestinal, and urinary systems.

SEE ALSO...

Items 21 to 24 of 24 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

(R)-(-)-3-Quinuclidinyl benzilate

62869-69-6sc-264196
5 mg
$166.00
(0)

(R)-(-)-3-Quinuclidinyl benzilate exhibits a unique affinity for muscarinic M3 receptors, characterized by its ability to induce allosteric modulation. This compound's steric configuration allows for specific interactions that stabilize receptor conformations, influencing downstream signaling pathways. Its lipophilic nature enhances membrane permeability, facilitating rapid receptor engagement. The compound's kinetic profile reveals a distinct binding mechanism, providing insights into receptor activation dynamics.

Aclidinium Bromide

320345-99-1sc-480200
100 mg
$388.00
(0)

Aclidinium, a long-acting mAChR M3 antagonist, is studied in the research of COPD. By inhibiting mAChR M3 in the airways, it promotes bronchodilation and helps manage respiratory symptoms associated with COPD, such as shortness of breath and coughing.

Tropicamide

1508-75-4sc-202371
100 mg
$32.00
3
(1)

Tropicamide, a muscarinic receptor antagonist, inhibits mAChR M3 in the eye. By inducing pupil dilation and preventing accommodation during eye examinations, it serves as a mydriatic and cycloplegic agent. Its inhibition of mAChR M3 contributes to the desired ocular effects.

L-Hyoscyamine

101-31-5sc-295290
sc-295290A
1 g
5 g
$222.00
$408.00
(0)

Hyoscyamine, a tropane alkaloid, acts as a mAChR M3 antagonist, exerting antispasmodic effects in smooth muscles. Its inhibition of muscarinic receptors helps alleviate symptoms of gastrointestinal disorders, such as irritable bowel syndrome (IBS), by reducing smooth muscle contractions and promoting relaxation.